Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:774-780

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orlov, S. N.
Right arrow Articles by Hamet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orlov, S. N.
Right arrow Articles by Hamet, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

(Hypertension. 1996;27:774-780.)
© 1996 American Heart Association, Inc.


Articles

cAMP Signaling Inhibits Dihydropyridine-Sensitive Ca2+ Influx in Vascular Smooth Muscle Cells

Sergei N. Orlov; Johanne Tremblay; Pavel Hamet

From the Centre de Recherche Hôtel-Dieu de Montréal, Université de Montréal (Québec), Canada.

Correspondence to Pavel Hamet, MD, PhD, Laboratory of Molecular Pathophysiology, Centre de Recherche Hôtel-Dieu de Montréal, 3850 St. Urbain St, Montréal, Québec H2W 1T8, Canada.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract This study examines the role of the cAMP signaling pathway in the regulation of 45Ca influx in cultured vascular smooth muscle cells from the rat aorta. K+o-induced depolarization of smooth muscle cells increased the rate of 45Ca uptake by twofold to threefold. This effect was completely abolished by the dihydropyridine derivatives nifedipine and nicardipine, with a Ki of 3 and 10 nmol/L, respectively. Activators of cAMP signaling (isoproterenol, forskolin, cholera toxin) increased cAMP content by 50- to 100-fold and decreased voltage-dependent 45Ca uptake by 50% to 70%. Neither the dihydropyridines nor the cAMP activators affected basal 45Ca influx. Direct addition of the protein kinase inhibitor H-89 to the incubation medium in the 1- to 10-µmol/L range did not alter basal 45Ca uptake but completely abolished voltage-dependent Ca2+ transport. Preincubation of cells for 1 hour with 10 µmol/L H-89 did not modify basal and depolarization-induced 45Ca uptake in H-89–free medium but prevented forskolin-induced inhibition of voltage-dependent Ca2+ influx. The addition of cytoskeleton-active compounds reduced voltage-dependent Ca2+ transport and completely abolished its regulation by cAMP. Activation of cAMP signaling decreased the volume of smooth muscle cells by 12% to 15%. The same cell volume diminution in hyperosmotic medium did not alter voltage-dependent 45Ca uptake. Thus, data obtained in this study show that in contrast to cardiac and skeletal myocytes, in vascular smooth muscle cells, 45Ca influx, putatively due to L-type channels, is inhibited by cAMP. This regulatory pathway appears to be mediated via protein kinase A activation and cytoskeleton reorganization.


Key Words: muscle, smooth, vascular • calcium channels • cyclic AMP • cytoskeleton


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Several years ago, we presented evidence that isoproterenol infusion induced a stronger increment of plasma cAMP levels in young subjects with labile hypertension than in age-matched control subjects. We compared this exaggerated responsiveness to ß-adrenergic stimulation with the diminished reaction observed in older hypertensive patients with low plasma renin activity.1 2 Viewing these results together with data on abnormalities of the cAMP signaling system obtained in cells and isolated membrane fractions from patients with essential hypertension and from spontaneously hypertensive rats, we proposed that augmented responsiveness to ß-adrenergic stimulation plays a key role in enhanced cardiac output revealed in labile hypertension, whereas decreased responsiveness of this system in chronic hypertension is involved in the progressive increase of total peripheral resistance via cAMP-mediated modulation of VSMC relaxation and/or growth and proliferation (for more details, see Reference 3).

Despite numerous data on cAMP-induced vasorelaxation, the mechanism of this phenomenon is poorly understood. The initial hypothesis on cAMP-induced decrease of Ca2+ sensitivity of myosin light-chain kinase was based on reversible phosphorylation of this enzyme from turkey gizzard smooth muscle by protein kinase A in vitro.4 This observation was subsequently confirmed in tracheal smooth muscle cells.5 However, to the best of our knowledge, there are no data on cAMP-induced phosphorylation of myosin light-chain kinase in VSMCs or on the correlation of smooth muscle relaxation and cAMP-induced phosphorylation of this enzyme in vivo. On the contrary, it has been shown that forskolin-induced relaxation of carotid arteries is not associated with altered Ca2+ sensitivity of myosin light-chain kinase.6

It may be assumed that apart from the modulation of activity of Ca2+-sensitive enzymes involved in excitation-contraction coupling, cAMP affects intracellular Ca2+ concentration. Indeed, in cardiac muscle, ß-adrenergic activation of cAMP signaling is accompanied by phosphorylation of the 22-kD protein phospholamban, which leads to severalfold activation of the sarcoplasmic reticulum Ca2+ pump.7 In VSMCs, phospholamban phosphorylation occurs at the same site as in cardiac cells but is mediated predominantly by cGMP-dependent protein kinase (for more details, see Reference 8). Several types of protein kinases, in particular protein kinase A, inhibit pharmacomechanical coupling triggered by the activation of ion channel and phospholipase C–coupled receptors.9 However, this mechanism cannot explain the inhibition of electromechanical coupling in VSMCs by cAMP.

Several years ago, Ousterhout and Sperelakis10 reported that both isoproterenol and forskolin depressed Ca2+-dependent action potential in depolarized cultured VSMCs. These results suggest that cAMP inhibits electromechanical coupling by membrane hyperpolarization and/or inactivation of VDCCs. Pharmacological studies indicate that cAMP-induced membrane hyperpolarization of VSMCs is mediated by activation of K+ channels.11 Indeed, in vascular and tracheal smooth muscles, direct evidence has been obtained by the patch-clamp technique of membrane-delimited Gs protein–mediated and cytoplasmic protein kinase A–mediated pathways of ß-adrenergic receptor coupling with Ca2+-activated K+ channels.12 13 14

In contrast to K+ channels, data on the modulation of VDCCs in VSMCs by cAMP are contradictory. Thus, dialysis with cAMP solutions had no effect on Ca2+ current in VSMCs from the rabbit saphenous artery15 and rat portal vein.16 Benham and Tsien17 reported a threefold increase of DHP-sensitive long-lasting (L-type) Ca2+ current in smooth muscle cells from the rabbit ear artery treated with norepinephrine. However, this effect was not mediated via known subtypes of ß- or {alpha}-adrenergic receptors.17 Ishikawa and coworkers18 reported that low concentrations of intracellular cAMP produce modest increases in whole-cell L-type Ca2+ channel current, whereas higher cAMP concentrations result in strong inhibition of L-type channel activity in VSMCs from the rabbit portal vein. Membrane-permeable cAMP analogues slightly inhibit slow, inward, long-lasting (L-type) Ca2+ channels in VSMCs isolated from the rat tail artery19 and in cultured cells from the rabbit aorta.20 Sustained inhibition of L-type Ca2+ was shown in freshly isolated smooth muscle cells from the rabbit portal vein treated with forskolin and 8-bromo-cAMP.21 In the A7r5 cell line derived from rat embryonic smooth muscle22 and in VSMCs from the porcine coronary artery,23 forskolin increases L-type VDCC-mediated Ca2+ current. In contrast, Lorenz and coworkers24 demonstrated that both cAMP analogues and forskolin inhibit L-type VDCCs in A7r5 cells.

These contradictory results on the regulation of VDCCs by cAMP signaling are probably caused by difficulties in obtaining satisfactory whole-cell voltage-clamp recordings from small myocytes and by rapid rundown of VDCC activity. Furthermore, enzymatic digestion in Ca2+-free medium during VSMC preparation can leave dispersed or primary cultured cells with drastically altered calcium homeostasis and membrane-bound protein function.24 To overcome these problems, we studied the regulation of Ca2+ inward fluxes in long-term cultured VSMCs by radioisotope methods. We report here that DHP-sensitive VD 45Ca influx in VSMCs from the rat aorta is inhibited by activators of cAMP signaling. Our results suggest that this regulatory pathway is mediated by activation of protein kinase A and cytoskeleton rearrangement.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
VSMCs were obtained by the explant method from the aortas of 10- to 13-week-old Brown Norway (BN.lx) male rats (Department of Biology, Charles University, Prague, Czech Republic) as described previously in detail.25 The cells reached confluency at 7 to 10 days and exhibited a hill-and-valley pattern typical of smooth muscle cells in culture. They were then passaged by treatment with 0.05% trypsin (Gibco) in Ca2+- and Mg2+-free Dulbecco's phosphate-buffered saline and incubated in 80-cm2 tissue culture flasks at a density of 105 cells/mL. This study was performed on VSMCs between passages 14 and 18. Under these conditions, the VSMCs reacted positively to specific smooth muscle myosin antibodies, as examined by fluorescence microscopy.26 Before experimentation, the cells were plated and allowed to grow for 20 to 24 hours in DMEM containing 10% calf serum. To establish quiescence, the growing medium was aspirated and the cells were supplied with DMEM containing 0.2% calf serum. After 48 to 72 hours, this medium was aspirated and replaced by a physiologically balanced salt solution immediately before the experiments began (see below). Cellular protein content was determined by a modification of the Lowry method.27 Intracellular cAMP content in VSMCs was assessed by radioimmunoassay.28

45Ca influx was measured essentially as described earlier,29 with changes in composition of the incubation media. Confluent, quiescent cultures of VSMCs (in 24-well plates) were washed twice at room temperature with 2-mL aliquots of medium A containing 150 mmol/L NaCl and 10 mmol/L HEPES-Tris (pH 7.4). One milliliter of medium B (in mmol/L: NaCl 140, KCl 5, MgCl2 1, CaCl2 1, glucose 5, HEPES-Tris 20, pH 7.4) was added to each well. After 30 minutes of preincubation at 37°C, the medium was replaced by 0.25 mL of medium B containing 0.2 mmol/L CaCl2, and the cells were incubated for a further 10 to 20 minutes at 37°C. Where appropriate, the preincubation medium contained different compounds, as indicated in the figure and table legends. Thereafter, each well was supplemented with 0.25 mL of prewarmed (37°C) low-potassium or high-potassium medium containing 5 mmol/L KCl and 140 mmol/L NaCl, respectively (final concentration of K+ and Na+, 5 and 140 mmol/L, respectively) or 125 mmol/L KCl and 20 mmol/L NaCl (final concentration of K+ and Na+, 65 and 80 mmol/L, respectively) with 2 to 4 µCi/mL 45CaCl2. The osmolality of these media was decreased by reduction of the NaCl concentration or increased by the addition of sucrose. Previously, it was shown that under these conditions, the kinetics of 45Ca uptake by VSMCs is linear up to 10 minutes.29 To estimate the rate of unidirectional inward Ca2+ fluxes, the time of incubation with the isotope was limited to 5 minutes. Incubation was terminated by the addition of 2.5 mL ice-cold solution (medium C) containing 100 mmol/L MgCl2 and 10 mmol/L HEPES-Tris (pH 7.4). The dishes were transferred onto ice, and the cells were washed 5 times with 2.5 mL of ice-cold medium C. The cells were lysed with 1 mL of 4 mmol/L EDTA/1% sodium dodecyl sulfate, and radioactivity was quantified by liquid scintillation counting. 45Ca influx was calculated as A/an, where A is radioactivity in the cell lysate (cpm), a is specific radioactivity of the incubation medium (cpm/pmol), and n is the protein content per well (in micrograms). VD (depolarization-induced) Ca2+ influx was determined as the difference between the rate of 45Ca uptake in high- and low-potassium media. The volume of intracellular water in VSMCs was determined as [14C]urea available space.30

Chemicals
45CaCl2 was obtained from Amersham Inc; isoproterenol bitartrate, cytochalasin B, vinblastine, nifedipine, and nicardipine were purchased from Sigma; forskolin, cholera toxin, pertussis toxin, and H-89 (N-[2-([3-(40 bromophenyl)-2-propenyl]-lamino)ethyl]-5-isoquinolinesulfonamide) were procured from Calbiochem Novabiochem Corp; D-glucose, salts, and buffers were from Sigma, Gibco, and Anachemia, respectively.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Effect of Extracellular Potassium
The increase of extracellular K+ concentration in incubation medium from 5 to 10 or 15 mmol/L slightly decreased 45Ca influx in VSMCs (Fig 1Down). This effect was probably caused by VSMC hyperpolarization due to [K+]o-dependent activation of the electrogenic Na+,K+ pump.8 A further increase of [K+]o up to 40 mmol/L was accompanied by a sharp twofold to threefold elevation of 45Ca uptake by VSMCs.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Dependence of 45Ca uptake by VSMCs on extracellular potassium concentration. Medium B was aspirated 30 minutes after preincubation of cells, and 45Ca uptake was initiated by the addition of medium B containing 0.1 to 60 mmol/L KCl, 145 to 85 mmol/L NaCl (total concentration of monovalent cations, 145 mmol/L), 0.1 mmol/L CaCl2, and {approx}2 µCi/mL 45CaCl2. Means±SEM were obtained from three experiments performed in quadruplicate.

Dose Dependence of 45Ca Uptake on Nicardipine and Nifedipine in Low- and High-Potassium Media
Increased nicardipine and nifedipine concentrations from 10-9 to 10-6 mol/L did not significantly modify 45Ca uptake by VSMCs under basal (low-potassium medium) conditions (data not shown). Both DHP derivatives completely blocked depolarization-induced 45Ca uptake in a concentration-dependent manner with a Ki of {approx}3 and 10 nmol/L for nifedipine and nicardipine, respectively (Fig 2Down).



View larger version (24K):
[in this window]
[in a new window]
 
Figure 2. Effect of nicardipine and nifedipine on depolarization-induced 45Ca uptake by VSMCs. After 30 minutes of preincubation of cells, medium B was changed to 0.25 mL medium B containing 0.2 mmol/L CaCl2 without or with 2x10-9 to 2x10-6 mol/L nicardipine or nifedipine. Calcium uptake was initiated after 10 minutes by the addition of 0.25 mL low-potassium or high-potassium medium containing {approx}4 µCi/mL 45CaCl2. Depolarization-induced 45Ca uptake values in the absence of the DHPs were taken as 100%. Means±SEM were obtained in three experiments performed in duplicate.

Effect of cAMP Signaling System Modulators
Activators of ß-adrenergic receptors, adenylate cyclase, and Gs proteins (isoproterenol, forskolin, and cholera toxin, respectively) increased cAMP content in VSMCs by 50- to 100-fold (Table 1ADown). These compounds did not affect basal 45Ca influx and decreased depolarization-induced 45Ca uptake by 50% to 70%. Neither basal nor depolarization-induced 45Ca was sensitive to pertussis toxin, an inhibitor of Gi proteins. Nicardipine did not significantly modify the effect of isoproterenol on cAMP content but completely abolished cAMP-induced inhibition of 45Ca uptake in high-potassium medium (Table 1ADown).

Effect of Protein Kinase A Inhibitor
H-89 is known to be a powerful and selective inhibitor of cAMP-dependent protein kinase. Thus, in cell-free systems and at micromolar ATP concentrations, half-maximal inhibition of protein kinase A, protein kinase G, and protein kinase C activity by H-89 was observed at 0.05, 0.5, and 30 µmol/L, respectively.31 Due to the high intracellular ATP concentration and limited permeability across plasma membrane, this compound inhibits protein kinase A activity in intact cells with an ED50 of 5 to 10 µmol/L.31 As seen in Fig 3Down, simultaneous addition of 10 µmol/L H-89 with 45Ca did not modify basal 45Ca uptake but completely abolished the increment of 45Ca uptake in high-potassium medium. These results demonstrate that at the same concentration range as used for inhibition of protein kinase A activity in vivo, H-89 completely suppressed VD Ca2+ transport in VSMCs, probably because of the direct interaction with L-type Ca2+ channels. To overcome this problem, we treated VSMCs with 10 µmol/L H-89, washed the cells with BSA-containing medium to remove extracellular H-89, and then measured 45Ca uptake in H-89–free medium. As seen in Fig 4bDown, H-89 did not modify depolarization-induced 45Ca uptake under this protocol but abolished its regulation by forskolin. It is important to mention that neither basal nor forskolin-induced cAMP production was altered in H-89–treated VSMCs (Fig 4aDown).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Effect of H-89 on 45Ca uptake by VSMCs in low- and high-potassium media. Cells were incubated for 30 minutes in medium B and then for 10 minutes in medium B containing 0.2 mmol/L CaCl2. 45Ca uptake was initiated by the addition of 0.25 mL of low-potassium or high-potassium medium containing {approx}4 µCi/mL 45CaCl2. H-89, 2x10-7 to 2x10-5 mol/L, was added simultaneously with 45Ca. The data from two experiments performed in quadruplicate are presented as percentages compared with 45Ca uptake in low-potassium medium without H-89.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 4. Effect of forskolin and H-89 on cAMP content (a) and depolarization-induced 45Ca uptake (b) by VSMCs. Cells were preincubated for 1 hour in 1 mL medium B (control VSMCs) or in medium B containing 10 µmol/L H-89 (H-89–treated VSMCs). This medium was aspirated, and cells were washed with 3x2-mL aliquots of medium A and incubated for 5 minutes with 1 mL of medium B containing 0.1% BSA. The latter medium was aspirated, and cells were incubated in medium B without or with 10 µmol/L forskolin. In 15 minutes, VSMCs were used for measurement of cAMP content or 45Ca uptake. 45Ca uptake was initiated by the addition of 0.25 mL low-potassium or high-potassium medium containing {approx}4 µCi/mL 45CaCl2. Means±SEM were obtained from two (cAMP content) and four (45Ca uptake) experiments performed in triplicate (cAMP content) or quadruplicate (45Ca uptake). *P<.01.

Effect of Cytoskeleton Assembly Modulators
It is known that activation of cAMP signaling in VSMCs is accompanied by cell shape transition32 33 and cytoskeleton reorganization.34 We therefore compared the effects of modulators of cytoskeleton assembly and cell volume on 45Ca uptake by VSMCs. As seen in Table 1BDown, cytochalasin B and vinblastine decreased depolarization-induced 45Ca uptake in BN.lx VSMCs by 70% and 45%, respectively. It should be underscored, however, that the effects of these cytoskeleton modulators on Ca2+ transport in VSMCs were probably mediated by distinct mechanisms. Indeed, cytochalasin B, an inhibitor of actin polymerization in microfilament bundles, did not modify basal 45Ca uptake and decreased it by 35% in high-potassium medium. In contrast to cytochalasin B, vinblastine, a microtubule-disrupting compound, increased basal 45Ca uptake by 60% but did not affect it in high-potassium medium. Neither cytochalasin B nor vinblastine modified forskolin-induced cAMP production. However, in VSMCs treated with these compounds, forskolin did not lead to further decreases of depolarization-induced Ca2+ influx (Table 1BDown).

Effect of Cell Volume
Table 2Down shows that treatment of VSMCs with forskolin reduced VSMC volume by 12% to 15%, which is in accordance with data obtained on VSMCs treated with isoproterenol.33 The same cell volume decrease (from 3.1 to 2.4 µL/mg protein) induced by hyperosmotic shrinkage did not alter depolarization-induced 45Ca uptake by VSMCs (Fig 5Down, curve 3). Under the same conditions of cell shrinkage, we did not observe any changes of forskolin-induced cAMP production and its regulation of VD 45Ca uptake (Table 2Down). A further decrease of VSMC volume from 2.4 to 1.6 µL/mg protein completely blocked depolarization-induced 45Ca uptake (Fig 5Down).


View this table:
[in this window]
[in a new window]
 
Table 2. Cell Volume, cAMP Content and Depolarization-Induced 45Ca Uptake in VSMCs



View larger version (21K):
[in this window]
[in a new window]
 
Figure 5. Dependence of 45Ca uptake by VSMCs in low-potassium (curve 1) and high-potassium (curve 2) media on intracellular water volume. Curve 3 represents a depolarization-induced component of 45Ca uptake. After 30 minutes in medium B, the cells were aspirated, and 45Ca uptake was initiated by the addition of 0.5 mL low- or high-potassium medium B containing 0.1 mmol/L CaCl2 and {approx}4 µCi/mL 45CaCl2. The osmolality of these media was increased or decreased by the addition of sucrose or by reduction of NaCl concentration, respectively. Means±SEM were obtained from two experiments performed in quadruplicate.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The data obtained in the present study show that an increase of cAMP content in long-term cultured VSMCs from the rat aorta via activation of ß-adrenergic receptors (isoproterenol), Gs proteins (cholera toxin), or adenylate cyclase (forskolin) inhibits depolarization-induced 45Ca influx (Table 1Down). This parameter was completely blocked by DHPs with a Ki of 3 to 10 nmol/L (Fig 2Up), which is in accordance with the sensitivity of VSMC L-type Ca2+ channels to these compounds under depolarization conditions obtained with the patch-clamp technique.35 In the presence of DHPs, we did not observe any effect of activation of cAMP signaling on 45Ca uptake by VSMCs (Table 1Down). On the basis of these results, it may be concluded that the cAMP-induced decrease of VD 45Ca uptake in VSMCs is caused by inhibition of L-type Ca2+ channels. This conclusion is concordant with data on the effect of cAMP analogues19 20 and forskolin24 obtained by patch clamp in primary cultured VSMCs from the rabbit aorta20 and rat tail artery19 and in the A7r5 cell line derived from vascular smooth muscles24 but contradicts results obtained in other laboratories by the same methods for dispersed or primary cultured VSMCs from the rabbit saphenous artery,15 rat portal vein,16 rabbit ear artery,17 porcine coronary artery,23 and A7r5 cells.22 This discrepancy may be due to (1) different properties of signaling pathway in smooth muscle from different vessels and species, (2) modification of the properties of L-type Ca2+ channels during preparation of dispersed and primary cultured VSMCs, and (3) difficulties in recording L-type VDCCs by the electrophysiological approach because of rapid rundown of their activity under cell dialysis.


View this table:
[in this window]
[in a new window]
 
Table 1. Effect of Modulators of cAMP Signaling (A) and Cytoskeleton Assembly (B) on cAMP Content and 45Ca Uptake by VSMCs

Recently, it was reported that cAMP analogues inhibit L-type Ca2+ current in rat osteoblastic cells,36 indicating that this mechanism of VDCC regulation is not limited to VSMCs. On the other hand, it is well documented that in most electrically excitable tissues (cardiomyocytes, skeletal fibers, neurons), cAMP enhances L-type VDCCs (see References 37 through 39 for review). ß-Adrenergic regulation of ion channels can be mediated by cAMP-independent and cAMP-dependent pathways. The cAMP-independent membrane-delimited pathway is triggered by direct interaction of ion channels with the activated {alpha}-subunit of Gs proteins,40 whereas the cAMP-dependent cytoplasmic pathway probably involves the activation of protein kinase A.41 In our study, we did not find significant differences between isoproterenol, forskolin, and cholera toxin in the inhibition of VD Ca2+ influx in VSMCs (Table 1Up). In the presence of forskolin, isoproterenol did not lead to a further reduction of VD 45Ca uptake (data not shown). Inhibition of VD Ca2+ influx by forskolin (Fig 4Up) and isoproterenol (data not shown) was completely abolished by pretreatment of VSMCs with H-89, an inhibitor of protein kinase A. These results are in accordance with data on partial inhibition of L-type channels in VSMCs from rabbit portal vein by a catalytic subunit of protein kinase A21 and indicate that ß-adrenergic–induced inhibition of L-type VDCCs in VSMCs is mediated by the cytoplasmic protein kinase A pathway.

Protein kinase A–induced inhibition of VD Ca2+ influx in VSMCs may be caused by phosphorylation of (1) the L-type channel itself and, in particular, its {alpha}1-subunit possessing several potential phosphorylation sites or (2) a contiguous regulatory type of protein(s). The first hypothesis seems unlikely. Indeed, despite opposite effects of cAMP on L-type VDCCs in VSMCs and cardiomyocytes, cDNA sequencing has predicted high homology of their {alpha}1-subunits.42 Moreover, it has been shown that cAMP does not affect Ca2+ channel currents in Xenopus oocytes resulting from expression of the {alpha}1-subunit of VSMC VDCCs alone.43 Apart from the {alpha}1-subunit, a potential phosphorylation site for protein kinase A has also been demonstrated in the ß-subunit of skeletal muscle L-type VDCCs (see Reference 38 for review). Coexpression of the VSMC {alpha}1-subunit with the skeletal muscle ß-subunit led to twofold activation of VD Ca2+ current in Xenopus oocytes. It should be underscored, however, that the same results were obtained with coexpressed {alpha}1-subunit from cardiac myocytes.43

Searching for candidate proteins that could be involved in the inhibition of VD Ca2+ influx in VSMCs, we focused on cAMP-induced VSMC shape transition and cytoskeleton reorganization first reported by Smith32 and later confirmed in other laboratories.33 34 Data obtained in the present study show that reorganization of the cytoskeleton network with cytochalasin B and vinblastine inhibits VD 45Ca uptake in VSMCs and abolishes its regulation by cAMP signaling (Table 1BUp). These results demonstrate that intact cytoskeleton is necessary for proper Ca2+ channel functions and suggest that cAMP-induced cytoskeleton reorganization is involved in the inhibition of L-type channel activity. Here, it is important to underscore that cytoskeleton-mediated regulation of plasma membrane ion currents is not limited by L-type Ca2+ channels. Thus, it was recently shown that cytochalasin D reduces whole-cell peak Na+ current in rat and rabbit ventricular cardiac myocytes44 and prevents activation of cystic fibrosis transmembrane conductance regulator-mediated Cl- conductance in mouse mammary adrenocarcinoma by cAMP analogues.45

Apart from shape transition, cAMP induces a decrease of VSMC volume by 12% to 15% (Table 2Up). Keeping in mind numerous data on the volume-dependent regulation of ion transport,46 we assumed that cAMP-induced inhibition of VD Ca2+ influx could be mediated by VSMC shrinkage. However, results obtained with hyperosmotically shrunken VSMCs contradict this assumption. Indeed, as seen in Fig 5Up, moderate hyperosmotic shrinkage did not modify VD 45Ca uptake by VSMCs.

In conclusion, the present study demonstrates that in contrast to skeletal and cardiac myocytes, cAMP inhibits VD DHP-sensitive Ca2+ influx in cultured smooth muscle cells from the rat aorta. It may be assumed that this signaling pathway plays a key role in vasorelaxation triggered by adenylate cyclase–coupled receptors. The inhibitory effect of cAMP on L-type Ca2+ channels deserves further investigation to determine the mechanism of its interrelation with protein phosphorylation and cytoskeleton network rearrangement.


*    Selected Abbreviations and Acronyms
 
DHP = dihydropyridine
DMEM = Dulbecco's modified Eagle's medium
VD = voltage-dependent
VDCC = voltage-dependent Ca2+ channels
VSMC = vascular smooth muscle cell


*    Acknowledgments
 
This work was supported by grants from the Medical Research Council of Canada (MT-10803 and MT-11463), the Heart and Stroke Foundation of Canada, and Bayer Canada. Dr Tremblay is the recipient of a senior scholarship from Fonds de la Recherche en Santé du Québec, and Dr Orlov received a visiting professorship from the International Society of Hypertension, Pfizer Pharmaceutical Co. The technical assistance of Monique Poirier, the secretarial skills of Josée Bédard-Baker, and the editorial help of Ovid Da Silva are appreciated.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Lowder SC, Hamet P, Liddle GW. Contrasting effects of hypoglycemia on plasma renin activity and cyclic adenosine 3',5'-monophosphate (cyclic AMP) in low renin and normal renin essential hypertension. Circ Res. 1976;38:105-108. [Abstract/Free Full Text]

2. Messerli FH, Kuchel O, Hamet P, Tolis G, Guthrie GP Jr, Fraysse J, Nowaczynski W, Genest J. Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension. Circ Res. 1976;38(suppl 2):II-42-II-47.

3. Hamet P, Orlov SN, Tremblay J. Intracellular signalling mechanisms in hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management (Vol 1). 2nd ed. New York, NY: Raven Press; 1995:575-607.

4. Adelstein RS, Conti MA, Hathaway DR. Phosphorylation of smooth muscle myosin light chain kinase by the catalytic subunit of adenosine-3' 5'-monophosphate dependent protein kinase. J Biol Chem. 1978;253:8347-8350. [Abstract/Free Full Text]

5. Stull JT, Hsu LC, Tansey MG, Kamm KE. Myosin light chain kinase phosphorylation in tracheal smooth muscle. J Biol Chem. 1990;265:16683-16690. [Abstract/Free Full Text]

6. McDaniel NL, Rembold CM, Richard HM, Murphy RA. Cyclic AMP relaxes swine arterial smooth muscle predominantly by decreasing cell Ca2+ concentration. J Physiol. 1991;439:147-160. [Abstract/Free Full Text]

7. Lindemann JP, Jones LR, Hathaway DR, Henry BG, Watanabe AM. ß-Adrenergic stimulation of phospholamban phosphorylation and Ca2+-ATPase activity in guinea pig ventricles. J Biol Chem. 1993;258:464-471. [Free Full Text]

8. O'Donnell ME, Owen NE. Regulation of ion pump and carriers in vascular smooth muscle. Physiol Rev. 1994;74:683-721. [Free Full Text]

9. Chen XL, Rembold CM. Cyclic nucleotide-dependent regulation of Mn2+ influx, [Ca2+]i, and arterial smooth muscle relaxation. Am J Physiol. 1992;263:C468-C473. [Abstract/Free Full Text]

10. Ousterhout JM, Sperelakis N. Cyclic nucleotides depress action potentials in cultured aortic smooth muscle cells. Eur J Pharmacol. 1987;144:7-14. [Medline] [Order article via Infotrieve]

11. Stekiel WJ, Contney SJ, Rusch NJ. Altered ß-receptor control of in situ membrane potential in hypertensive rats. Hypertension. 1993;21:1005-1009. [Abstract/Free Full Text]

12. Sadoshima TI, Akaike N, Kanaide N, Nakamura M. Cyclic AMP modulates Ca-activated K channel in cultured smooth muscle cells of rat aortas. Am J Physiol. 1988;255:H754-H759. [Abstract/Free Full Text]

13. Kume H, Graziano MP, Kotlikoff MI. Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanosine-nucleotide-binding proteins. Proc Natl Acad Sci U S A. 1992;89:11051-11055. [Abstract/Free Full Text]

14. Scornik FS, Codina J, Birnbaumer L, Toro L. Modulation of coronary smooth muscle KCa channels by Gsa independent of phosphorylation by protein kinase A. Am J Physiol. 1993;265:H1460-H1465. [Abstract/Free Full Text]

15. Okie M, Kitamura K, Kuriyama H. Histamine H2-receptor activation augments voltage-dependent Ca2+ current via GTP hydrolysis in rabbit saphenous artery. J Physiol. 1992;448:133-152. [Abstract/Free Full Text]

16. Loirand G, Pacaud P, Mironneau C, Mironneau J. GTP-binding protein mediates noradrenaline effects on calcium and chloride currents in rat portal vein myocytes. J Physiol. 1990;428:517-529. [Abstract/Free Full Text]

17. Benham CD, Tsien RW. Noradrenaline modulation of calcium channels in single smooth muscle cells from rabbit ear aorta. J Physiol. 1988;404:767-788. [Abstract/Free Full Text]

18. Ishikawa T, Hume JR, Keef KD. Regulation of Ca2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circ Res. 1993;73:1128-1137. [Abstract/Free Full Text]

19. Wang R, Karpinski E, Pang PKT. Parathyroid hormone selectively inhibits L-type calcium channels in single vascular smooth muscle cells of the rat. J Physiol. 1991;441:325-346. [Abstract/Free Full Text]

20. Bkaily G, Yamamoto T, Peyrow M, Sculptoreanu A, Jacques D, Sperelakis N. Macroscopic Ca2+ and K+ currents in single cardiac and aortic cells. Mol Cell Biol. 1988;80:59-72.

21. Xiong Z, Sperelakis N, Fenoglio-Preiser C. Regulation of L-type calcium channels by cyclic nucleotides and phosphorylation in smooth muscle cells from rabbit portal vein. J Vasc Res. 1994;31:271-279. [Medline] [Order article via Infotrieve]

22. Marks TN, Dubyah GR, Jones SW. Calcium currents in the A7r5 smooth muscle-derived cell line. Pflugers Arch. 1990;417:433-439. [Medline] [Order article via Infotrieve]

23. Fukumitsu T, Hayaschi H, Tokuno H, Tomita T. Increase of calcium current by ß-adrenoceptor agonists in single smooth muscle cells isolated from porcine coronary artery. Br J Pharmacol. 1990;100:593-599. [Medline] [Order article via Infotrieve]

24. Lorenz JN, Bielefeld D, Sperelakis N. Regulation of calcium channel current in A7r5 vascular smooth muscle cells by cyclic nucleotides. Am J Physiol. 1994;266:C1656-C1663. [Abstract/Free Full Text]

25. Franks DJ, Plamondon J, Hamet P. An increase in adenylate cyclase activity precedes DNA synthesis in cultured vascular smooth muscle cells. J Cell Physiol. 1984;119:41-45. [Medline] [Order article via Infotrieve]

26. Hadrava V, Tremblay J, Hamet P. Effect of cell density and growth factors on proliferation of vascular smooth muscle cells from SHR. Proc. Sixth Annual Symposium on SHR and Related Studies. Iowa City, Iowa, May 22-24, 1989. Abstract.

27. Hartee EI. Determination of protein content: a modification of the Lowry method that gives a linear photometric response. Anal Biochem. 1972;48:422-427.[Medline] [Order article via Infotrieve]

28. Hamet P, Pang SC, Tremblay J. Atrial natriuretic factor-induced egression of cyclic guanosine 3':5'-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem. 1989;264:12364-12369. [Abstract/Free Full Text]

29. Orlov S, Resink TJ, Bernhardt J, Ferracin F, Bühler FR. Vascular smooth muscle cell calcium fluxes: regulation by angiotensin II and lipoproteins. Hypertension. 1993;21:195-203. [Abstract/Free Full Text]

30. Orlov SN, Resink TJ, Bernhardt J, Bühler FR. Volume-dependent regulation of sodium and potassium fluxes in cultured vascular smooth muscle cells: dependence on medium osmolality and regulation by signalling systems. J Membr Biol. 1992;129:199-210. [Medline] [Order article via Infotrieve]

31. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaha H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, compound H-89. J Biol Chem. 1990;265:5267-5272. [Abstract/Free Full Text]

32. Smith JB. Beta-adrenergic stimulation inhibits calcium efflux and alters the morphology of cultured arterial muscle cells. J Cell Physiol. 1984;121:375-382. [Medline] [Order article via Infotrieve]

33. Orlov SN, Tremblay J, Hamet P. Altered ß-adrenergic regulation of Na+, K+ cotransport in cultured smooth muscle cells from the aorta of spontaneously hypertensive rats: role of the cytoskeleton network. Am J Hypertens. 1995;8:739-747.[Medline] [Order article via Infotrieve]

34. Chaldakov GN, Nabika T, Nara T, Yamori Y. Cyclic AMP- and cytochalasin B-induced arborization in cultured aortic smooth muscle cells: its cytopharmacological characterization. Cell Tissue Res. 1989;255:432-442.

35. Kuga T, Sadoshima J, Tomoike H, Kanaide H, Akaike N, Nakamura M. Action of Ca2+ antagonists on two types of Ca2+ channels in rat aorta smooth muscle cells in primary culture. Circ Res. 1990;67:469-480. [Abstract/Free Full Text]

36. Fritsch J, Chesnoy-Marchais D. Dual modulation of the L-type calcium current of rat osteoblastic cells by parathyroid hormone: opposite effects of protein kinase C and cyclic nucleotides. Cell Signal. 1994;6:645-655. [Medline] [Order article via Infotrieve]

37. Kostyuk PG. Intracellular perfusion of nerve cells and its effects on membrane current. Physiol Rev. 1984;64:435-454. [Free Full Text]

38. McDonald TF, Pelzer S, Trautwein W, Pelzer D. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol Rev. 1994;74:365-507. [Free Full Text]

39. Sperelakis N, Tohse N, Ohya Y, Masuda H. Cyclic GMP regulation of calcium channels in cardiac and vascular smooth muscle cells. Adv Pharmacol. 1994;26:217-252.

40. Birnbaumer L, Abramowitz J, Brown AM. Receptor-effector coupling by G-proteins. Biochim Biophys Acta. 1990;1031:185-224.

41. Levitan IB. Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu Rev Physiol. 1994;56:193-212. [Medline] [Order article via Infotrieve]

42. Hullin R, Biel M, Flockerzi V, Hofmann F. Tissue specific expression of calcium channels. Trends Cardiovasc Med. 1993;3:45-53.

43. Klockner U, Itagaki K, Bodi I, Schwartz A. ß-Subunit expression is required for cAMP-dependent increase of cloned cardiac and vascular calcium channel currents. Pflugers Arch. 1992;420:413-415. [Medline] [Order article via Infotrieve]

44. Udrovinas AI, Shander GS, Makielski JC. Cytoskeleton modulates gating of voltage-dependent sodium channels in heart. Am J Physiol. 1995;269:H203-H214. [Abstract/Free Full Text]

45. Prat GA, Xiao YF, Ausiello DA, Cantiello H. cAMP-independent regulation of CFTR by the actin cytoskeleton. Am J Physiol. 1995;268:C1552-C1561. [Abstract/Free Full Text]

46. Hoffman EK, Simonsen LO. Membrane mechanisms in volume and pH regulation in vertebrate cells. Physiol Rev. 1989;69:315-382.[Free Full Text]




This article has been cited by other articles:


Home page
GutHome page
M Hennenberg, J Trebicka, T Sauerbruch, and J Heller
Mechanisms of extrahepatic vasodilation in portal hypertension
Gut, September 1, 2008; 57(9): 1300 - 1314.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H.-Y. Zhang, Y. Shirasawa, X. Chen, H. Yu, and J. N. Benoit
Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature
Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G603 - G608.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. R. Gosmanov, Z. Fan, X. Mi, E. G. Schneider, and D. B. Thomason
ATP-sensitive potassium channels mediate hyperosmotic stimulation of NKCC in slow-twitch muscle
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C586 - C595.
[Abstract] [Full Text]


Home page
J. Physiol.Home page
S. Taurin, N. O Dulin, D. Pchejetski, R. Grygorczyk, J. Tremblay, P. Hamet, and S. N Orlov
c-Fos expression in ouabain-treated vascular smooth muscle cells from rat aorta: evidence for an intracellular-sodium-mediated, calcium-independent mechanism
J. Physiol., September 15, 2002; 543(3): 835 - 847.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. E. PURDY and W. J. ARENDSHORST
Iloprost Inhibits Inositol-1,4,5-Trisphosphate-Mediated Calcium Mobilization Stimulated by Angiotensin II in Cultured Preglomerular Vascular Smooth Muscle Cells
J. Am. Soc. Nephrol., January 1, 2001; 12(1): 19 - 28.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. L. Dodge, D. W. Carr, and B. M. Sanborn
Protein Kinase A Anchoring to the Myometrial Plasma Membrane Is Required for Cyclic Adenosine 3',5'-Monophosphate Regulation of Phosphatidylinositide Turnover
Endocrinology, November 1, 1999; 140(11): 5165 - 5170.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. S. Taylor and J. N. Benoit
Effect of milrinone on small mesenteric artery vasoconstriction: role of K+ channels
Am J Physiol Gastrointest Liver Physiol, July 1, 1999; 277(1): G69 - G78.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. D. STOCKAND and S. C. SANSOM
Glomerular Mesangial Cells: Electrophysiology and Regulation of Contraction
Physiol Rev, July 1, 1998; 78(3): 723 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Uhlig, R. L. Featherstone, H.-D. Held, R. Nüsing, C. Schudt, and A. Wendel
Attenuation by Phosphodiesterase Inhibitors of Lipopolysaccharide-Induced Thromboxane Release and Bronchoconstriction in Rat Lungs
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1453 - 1459.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. O. Dulin, J. Niu, D. D. Browning, R. D. Ye, and T. Voyno-Yasenetskaya
Cyclic AMP-independent Activation of Protein Kinase A by Vasoactive Peptides
J. Biol. Chem., June 8, 2001; 276(24): 20827 - 20830.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orlov, S. N.
Right arrow Articles by Hamet, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orlov, S. N.
Right arrow Articles by Hamet, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL